Display options
Cite
Sivamaruthi BS, Kesika P, Chaiyasut C. The Role of Probiotics in Colorectal Cancer Management. Evid Based Complement Alternat Med. 2020;2020:3535982doi: 10.1155/2020/3535982.
Sivamaruthi, B. S., Kesika, P., & Chaiyasut, C. (2020). The Role of Probiotics in Colorectal Cancer Management. Evidence-based complementary and alternative medicine : eCAM, 20203535982. https://doi.org/10.1155/2020/3535982
Sivamaruthi, Bhagavathi Sundaram, et al. "The Role of Probiotics in Colorectal Cancer Management." Evidence-based complementary and alternative medicine : eCAM vol. 2020 (2020): 3535982. doi: https://doi.org/10.1155/2020/3535982
Sivamaruthi BS, Kesika P, Chaiyasut C. The Role of Probiotics in Colorectal Cancer Management. Evid Based Complement Alternat Med. 2020 Feb 14;2020:3535982. doi: 10.1155/2020/3535982. eCollection 2020. PMID: 32148539; PMCID: PMC7048916.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2020 Feb 14;2020:3535982. doi: 10.1155/2020/3535982. eCollection 2020.

The Role of Probiotics in Colorectal Cancer Management.

Evidence-based complementary and alternative medicine : eCAM

Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Chaiyavat Chaiyasut

Affiliations

  1. Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

PMID: 32148539 PMCID: PMC7048916 DOI: 10.1155/2020/3535982

Abstract

Colorectal cancer (CRC) is one of the most common cancerous diseases worldwide and causes leading cancer-associated deaths. Several factors are related to the incidence of CRC such as unhealthy diet and lifestyle, heredity, metabolic disorders, and genetic factors. Even though several advanced medical procedures are available for CRC treatment, the survival rates are poor with many adverse treatments associated side effects, which affects the quality of life. Probiotics are a well-known bioactive candidate for the treatment of several diseases and ill-health conditions. The recent scientific evidence suggested that probiotic supplementation protects the CRC patients from treatment-associated adverse effects. The manuscript summarizes the influence of probiotic supplementation on the health status of CRC patients and discusses the possible mechanism behind the protective effect of probiotics against CRC. The literature survey revealed that beneficial impact of probiotic supplementation depends on several factors such as strain, dosage, duration of the intervention, host physiology, and other food supplements. The probiotic intervention improves the microbiota, releases antimicrobials and anticarcinogenic agents, helps to remove carcinogens, and improves the intestinal permeability, tight junction function, and enzyme activity in CRC patients. Besides, not all probiotic strains exhibit anti-CRC activities; it is necessary to screen the potent strain for the development of a probiotic-based therapeutic agent to control or prevent the incidence of CRC.

Copyright © 2020 Bhagavathi Sundaram Sivamaruthi et al.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

  1. J Med Microbiol. 2013 Aug;62(Pt 8):1107-1123 - PubMed
  2. J Appl Microbiol. 2014 Jul;117(1):208-16 - PubMed
  3. J Biosci. 2015 Jun;40(2):269-79 - PubMed
  4. World J Gastroenterol. 2010 Jan 14;16(2):167-75 - PubMed
  5. J Nutr. 2006 Jun;136(6):1483-7 - PubMed
  6. Food Sci Nutr. 2018 Nov 05;7(1):216-224 - PubMed
  7. Probiotics Antimicrob Proteins. 2019 Dec;11(4):1155-1162 - PubMed
  8. Int J Colorectal Dis. 2019 Mar;34(3):459-469 - PubMed
  9. J Gastroenterol. 2016 Sep;51(9):862-73 - PubMed
  10. J Microbiol Biotechnol. 2016 Aug 28;26(8):1490-503 - PubMed
  11. Eur J Cancer Prev. 2014 Nov;23(6):550-9 - PubMed
  12. Biochem Soc Trans. 2003 Apr;31(2):381-3 - PubMed
  13. Medicine (Baltimore). 2016 Apr;95(15):e3342 - PubMed
  14. Medicines (Basel). 2018 Sep 07;5(3): - PubMed
  15. Rejuvenation Res. 2014 Aug;17(4):325-33 - PubMed
  16. J Cancer. 2017 Sep 20;8(17):3378-3395 - PubMed
  17. PLoS One. 2012;7(4):e34676 - PubMed
  18. Nutr Cancer. 2018 Aug-Sep;70(6):946-955 - PubMed
  19. J Microbiol. 2015 Jun;53(6):398-405 - PubMed
  20. Tumour Biol. 2013 Jun;34(3):1285-300 - PubMed
  21. Cancer Lett. 2014 Apr 10;345(2):258-70 - PubMed
  22. Cancer Sci. 2018 Mar;109(3):666-677 - PubMed
  23. Food Funct. 2016 Apr;7(4):1731-40 - PubMed
  24. Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G851-9 - PubMed
  25. Am J Physiol Gastrointest Liver Physiol. 2011 Dec;301(6):G1004-13 - PubMed
  26. J Clin Oncol. 2003 Feb 1;21(3):433-40 - PubMed
  27. Eur J Pharmacol. 2018 Aug 15;833:396-402 - PubMed
  28. World J Microbiol Biotechnol. 2014 Feb;30(2):351-74 - PubMed
  29. Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):406-15 - PubMed
  30. Am J Clin Nutr. 2009 Sep;90(3):578-86 - PubMed
  31. Cell Physiol Biochem. 2017;42(6):2330-2341 - PubMed
  32. Am J Clin Nutr. 2013 Jan;97(1):117-26 - PubMed
  33. Coll Antropol. 2016 Apr;40(1):35-40 - PubMed
  34. Nutr Clin Pract. 2012 Oct;27(5):624-35 - PubMed
  35. Nutr Cancer. 2012 Aug;64(6):871-8 - PubMed
  36. Mol Med Rep. 2015 Oct;12(4):6119-27 - PubMed
  37. Dig Liver Dis. 2014 Dec;46(12):1126-32 - PubMed
  38. Nutr Cancer. 2012;64(7):1103-11 - PubMed
  39. Oncotarget. 2016 Feb 16;7(7):8432-40 - PubMed
  40. Int J Inflam. 2010 Oct 31;2010:894972 - PubMed
  41. Nutr Cancer. 2010;62(3):371-8 - PubMed
  42. Aliment Pharmacol Ther. 2011 Jan;33(1):50-63 - PubMed
  43. Ann Gastroenterol. 2016 Jan-Mar;29(1):56-62 - PubMed
  44. Sci Rep. 2013 Oct 08;3:2868 - PubMed
  45. Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G315-22 - PubMed
  46. Complement Ther Med. 2015 Jun;23(3):356-62 - PubMed
  47. Nutr Res. 2017 Jan;37:1-19 - PubMed
  48. Genomics Proteomics Bioinformatics. 2018 Feb;16(1):33-49 - PubMed
  49. Am J Gastroenterol. 2001 Oct;96(10):2992-3003 - PubMed
  50. BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145 - PubMed
  51. Carcinogenesis. 2010 Feb;31(2):246-51 - PubMed
  52. Free Radic Biol Med. 2014 Mar;68:122-33 - PubMed
  53. J Gastroenterol Hepatol. 2016 Aug;31(8):1453-61 - PubMed
  54. Int J Food Microbiol. 2008 Dec 10;128(2):406-10 - PubMed
  55. Appl Biochem Biotechnol. 2012 Feb;166(3):620-31 - PubMed
  56. Appl Microbiol Biotechnol. 2017 Mar;101(5):1999-2019 - PubMed
  57. Anaerobe. 2014 Dec;30:129-36 - PubMed
  58. Arch Iran Med. 2015 Mar;18(3):167-72 - PubMed
  59. Nat Rev Microbiol. 2012 Jun 25;10(8):575-82 - PubMed
  60. Gastroenterology. 2010 Jun;138(6):2101-2114.e5 - PubMed
  61. PLoS One. 2017 Dec 7;12(12):e0189257 - PubMed
  62. World J Surg. 2015 Nov;39(11):2776-83 - PubMed
  63. BMC Cancer. 2018 Nov 13;18(1):1111 - PubMed
  64. Molecules. 2017 Jan 10;22(1): - PubMed
  65. Br J Cancer. 2007 Oct 22;97(8):1028-34 - PubMed
  66. Biomed Pharmacother. 2016 Oct;83:536-541 - PubMed
  67. Nutr Cancer. 2013;65(1):84-91 - PubMed
  68. World J Surg. 2016 Aug;40(8):1985-92 - PubMed
  69. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  70. Am J Clin Nutr. 2007 Feb;85(2):488-96 - PubMed
  71. Transl Gastroenterol Hepatol. 2017 Aug 23;2:67 - PubMed
  72. Biomed Res Int. 2019 May 9;2019:3291367 - PubMed
  73. Oncotarget. 2016 Feb 9;7(6):7161-78 - PubMed
  74. Curr Colorectal Cancer Rep. 2017 Dec;13(6):440-454 - PubMed
  75. Biotechnol Lett. 2009 Apr;31(4):571-6 - PubMed
  76. Nutr Res. 2017 May;41:36-46 - PubMed
  77. Dig Dis. 2016;34(3):244-50 - PubMed
  78. Science. 2012 Oct 5;338(6103):120-3 - PubMed
  79. Asia Pac J Clin Oncol. 2018 Jun;14(3):179-191 - PubMed
  80. Iran J Basic Med Sci. 2014 Oct;17(10):815-9 - PubMed
  81. Int J Cancer. 2005 Sep 20;116(5):762-7 - PubMed
  82. World J Gastroenterol. 2007 Feb 14;13(6):912-5 - PubMed
  83. Exp Ther Med. 2015 Sep;10(3):966-972 - PubMed

Publication Types